NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286,433 | -18.2% | 6,902 | +18.6% | 0.00% | – |
| Q1 2023 | $349,954 | -33.8% | 5,819 | -19.3% | 0.00% | – |
| Q4 2022 | $528,780 | +10.6% | 7,209 | +14.4% | 0.00% | – |
| Q3 2022 | $478,000 | +32.8% | 6,300 | +22.0% | 0.00% | – |
| Q2 2022 | $360,000 | -10.4% | 5,165 | +6.4% | 0.00% | – |
| Q1 2022 | $402,000 | +33.6% | 4,853 | +21.3% | 0.00% | – |
| Q4 2021 | $301,000 | -43.0% | 4,002 | -12.1% | 0.00% | – |
| Q3 2021 | $528,000 | -54.9% | 4,553 | -13.6% | 0.00% | – |
| Q2 2021 | $1,170,000 | -2.9% | 5,271 | -42.2% | 0.00% | – |
| Q1 2021 | $1,205,000 | -93.3% | 9,113 | -91.2% | 0.00% | -100.0% |
| Q4 2020 | $17,928,000 | +7561.5% | 103,609 | +4822.0% | 0.01% | – |
| Q3 2020 | $234,000 | – | 2,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |